Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co ElifiledCriticalLilly Co Eli
Priority to CO95007821ApriorityCriticalpatent/CO4340678A1/en
Publication of CO4340678A1publicationCriticalpatent/CO4340678A1/en
REIVINDICACION NUMERO UNA FORMULACION SUBSTANCIALMENTE NO ACUOSA PARA ADMINISTRACION ORAL DE UN AGENTE FARMACEUTICO, CARACTERIZADA PORQUE COMPRENDE DE: (1) UN AGENTE FARMACEUTICO QUE ES SUBSTANCIALMENTE NO ACUOSO EN EL CUAL, EL AGUA Y (2) UN PORTADOR SUBSTANCIALMENTENO ACUOSO EN EL CUAL, EL AGENTE ESTA SOLUBILIZADO, EL PORTADOR COMPRENDE UN AGENTE SOLUBILIZANTE DE ACIDO GRASO DE CADENA LARGA, UN ACEITE ACEPTABLE FARMACEUTICAMENTE Y UN AGENTE ACTIVO DE SUPERFICIE".CLAIMED NUMBER A SUBSTANTIALLY NON-WATER FORMULATION FOR ORAL ADMINISTRATION OF A PHARMACEUTICAL AGENT, CHARACTERIZED BECAUSE IT INCLUDES: (1) A PHARMACEUTICAL AGENT WHO IS SUBSTANTIALLY NOT AQUATIC, THE WATER AND (2) A SUBSTANTIAL ELEMENTARY WATER AGENT IS SOLUBILIZED, THE CARRIER INCLUDES A LONG CHAIN FATTY ACID SOLUBILIZING AGENT, A PHARMACEUTICALLY ACCEPTABLE OIL AND AN ACTIVE SURFACE AGENT. "
CO95007821A1995-02-281995-02-28
FORMULATIONS FOR PHARMACEUTICAL AGENTS ADMINISTERED IN ORAL FORM
CO4340678A1
(en)